Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,874
Total Claims
$809K
Drug Cost
795
Beneficiaries
$1,018
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,186 Anesthesiology providers
+80%
Opioid rate vs peers
62.7% vs 34.8% avg
+141%
Cost per patient vs peers
$1,018 vs $422 avg
-12%
Brand preference vs peers
4.2% vs 4.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
62.7%
Opioid Rate
6,815
Opioid Claims
$515K
Opioid Cost
18.0%
Long-Acting Rate
This provider's opioid prescribing rate of 62.7% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 455 claims · $432K
Generic: 10,419 claims · $378K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Methylnaltrexone Bromide | 52 | $124K |
| Oxycodone Myristate | 127 | $123K |
| Hydrocodone/Acetaminophen | 3,181 | $114K |
| Oxycodone Hcl | 55 | $76K |
| Fentanyl | 456 | $63K |
| Oxycodone Hcl/Acetaminophen | 770 | $29K |
| Oxycodone Hcl | 657 | $21K |
| Linaclotide | 25 | $19K |
| Gabapentin Enacarbil | 14 | $18K |
| Gabapentin | 853 | $17K |
| Naloxone Hcl | 195 | $17K |
| Cariprazine Hcl | 11 | $16K |
| Tapentadol Hcl | 17 | $15K |
| Buprenorphine | 33 | $15K |
| Morphine Sulfate | 269 | $12K |
Prescribing Profile
44
Unique Drugs
21.0
Anomaly Score
Patient Profile
71
Avg Age
64%
Female
1.62
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data